PG
AGN

Pendal Group’s Allergan plc AGN Stock Holding History

Pendal Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,407
Closed -$1.31M – 531
2020
Q1 		$1.31M Sell
7,407
-4,374
-37% -$824K 0.02% 193
2019
Q4 		$2.25M Hold
11,781
– – 0.03% 196
2019
Q3 		$1.98M Buy
+11,781
New +$1.92M 0.03% 217
2017
Q3 		– Sell
-2,175
Closed -$529K – 506
2017
Q2 		$529K Buy
+2,175
New +$511K 0.01% 359

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pendal Group's AGN Position: Q2 2020 in Review

Pendal Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,407 shares — an estimated $1.31M sold.

Pendal Group first reported a position in AGN in Q2 2017 and held it in 4 quarters. The position peaked at $2.25M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pendal Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pendal Group sold 7,407 Allergan plc shares in Q2 2020, an estimated $1.31M.
  • Pendal Group first reported a position in Allergan plc in Q2 2017 and held it in 4 quarters.
  • Pendal Group's Allergan plc position peaked at $2.25M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pendal Group's 13F filing for Q2 2020, filed 7 Aug 2020.